MetaADEDB 2.0 @ LMMD
Ethambutol
(AUAHHJJRFHRVPV-BZDVOYDHSA-N)
Structure
SMILES
CC[C@H](NCCN[C@H](CO)CC)CO.Cl.Cl
Molecular Formula:
C10H26Cl2N2O2
Molecular Weight:
277.232
Log P:
2.0932
Hydrogen Bond Acceptor:
4
Hydrogen Bond Donor:
6
TPSA:
64.52
CAS Number(s):
1070-11-7
Synonym(s)
1.
Ethambutol
2.
Dexambutol
3.
EMB-Fatol
4.
EMB-Hefa
5.
Etambutol Llorente
6.
Ethambutol Hydrochloride
7.
Etibi
8.
Miambutol
9.
Myambutol
10.
EMB Fatol
11.
EMB Hefa
12.
Hydrochloride, Ethambutol
13.
Llorente, Etambutol
External Link(s)
MeSHD004977
PubChem Compound14051
46878363
46911976
ChEBI4878
CHEMBLCHEMBL3140361
KEGGdr:D00878
Adverse Drug Event(s)
NameNumber of ReportsReference(s)Data Source
1BlindnessFAERS: 7US FAERS
2Optic NeuritisFAERS: 5
Canada Vigilance: 1
Canada Vigilance
US FAERS
3Visual ImpairmentFAERS: 3
Canada Vigilance: 5
Canada Vigilance
US FAERS
4Drug toxicityFAERS: 2US FAERS
5SepsisFAERS: 2US FAERS
6ArthralgiaFAERS: 1US FAERS
7CataractFAERS: 1US FAERS
8Chest PainFAERS: 1US FAERS
9ChromatopsiaFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
10Drug prescribing errorFAERS: 1US FAERS
11GastroenteritisFAERS: 1US FAERS
12GoutFAERS: 1US FAERS
13HypotensionFAERS: 1US FAERS
14Immune thrombocytopenic purpuraFAERS: 1US FAERS
15Macular degenerationFAERS: 1US FAERS
16Medication ErrorFAERS: 1US FAERS
17Myocardial InfarctionFAERS: 1US FAERS
18Myocardial necrosisFAERS: 1US FAERS
19Optic AtrophyFAERS: 1US FAERS
20OverdoseFAERS: 1US FAERS
21PyelonephritisFAERS: 1US FAERS
22Retinal DetachmentFAERS: 1US FAERS
23Stevens-Johnson SyndromeFAERS: 1US FAERS
24Systemic Inflammatory Response SyndromeFAERS: 1US FAERS
25Toxic Epidermal NecrolysisFAERS: 1US FAERS
26Toxic Optic NeuropathyFAERS: 1US FAERS
27Toxicity to various agentsFAERS: 1US FAERS
28TuberculosisFAERS: 1US FAERS
29Visual disturbanceFAERS: 1US FAERS
30VomitingFAERS: 1US FAERS
31Walking aid userFAERS: 1US FAERS
32AlopeciaCanada Vigilance: 1Canada Vigilance
33AstheniaCanada Vigilance: 2Canada Vigilance
34ChillsCanada Vigilance: 2Canada Vigilance
35DermatitisCanada Vigilance: 1Canada Vigilance
36DiplopiaCanada Vigilance: 1Canada Vigilance
37DizzinessCanada Vigilance: 3Canada Vigilance
38EosinophiliaCanada Vigilance: 1Canada Vigilance
39ErythemaCanada Vigilance: 1Canada Vigilance
40HeadacheCanada Vigilance: 2Canada Vigilance
41NauseaCanada Vigilance: 2Canada Vigilance
42PhotophobiaCanada Vigilance: 1Canada Vigilance
43PruritusCanada Vigilance: 1Canada Vigilance
Powered by :

Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120236

Copyright © 2019-2020 Laboratory of Molecular Modeling and Design, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology. All rights reserved.